Intensify Chemotherapy or Activate Immunity? Balancing INTERLACE and KEYNOTE-A18 in Locally Advanced Cervical Cancer
Global Advances in Oncology and Hematology · 2026-09 · 1 (1) · 28-30
DOI: 10.4103/gaoh.gaoh_8_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Advances in Oncology and Hematology, online erschienen am 05.09.2026. Verfasst von David Atallah und 4 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Atallah, D., Naim, N., Kassis, N. E., Kourie, H. R., & Chahine, G. (2026). Intensify Chemotherapy or Activate Immunity? Balancing INTERLACE and KEYNOTE-A18 in Locally Advanced Cervical Cancer. Global Advances in Oncology and Hematology, 1(1), 28-30. https://doi.org/10.4103/gaoh.gaoh_8_26
Vancouver
Atallah D, Naim N, Kassis NE, Kourie HR, Chahine G. Intensify Chemotherapy or Activate Immunity? Balancing INTERLACE and KEYNOTE-A18 in Locally Advanced Cervical Cancer. Global Advances in Oncology and Hematology. 2026;1(1):28-30. doi:10.4103/gaoh.gaoh_8_26
BibTeX
@article{Atallah2026,
author = {Atallah, David and Naim, Nabih and Kassis, Nadine El and Kourie, Hampig Raphael and Chahine, Georges},
title = {Intensify Chemotherapy or Activate Immunity? Balancing INTERLACE and KEYNOTE-A18 in Locally Advanced Cervical Cancer},
journal = {Global Advances in Oncology and Hematology},
year = {2026},
volume = {1},
number = {1},
pages = {28--30},
doi = {10.4103/gaoh.gaoh_8_26}
}
EUVIMED